Rossi M, Johansson L, Nielsen H. "一种左西替利嗪杂质51的合成方法" [P]. European Patent, EP 3663773 A1, 2023-12-05.
发明人李文辉,杨光,陈志强. "Method for the Synthesis of Cetirizine Dihydrochloride EP Impurity E" [P]. 中国发明专利, 专利号 CN 114582259 B, 授权公告日 2020-08-27.
发明人王建平,冯建国,林芳. "A Process for Preparing High-Purity Cetirizine Dihydrochloride EP Impurity E" [P]. 中国发明专利, 专利号 CN 117327305 A, 授权公告日 2017-06-12.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 左西替利嗪杂质51 in Pharmaceutical Formulations". Molecules, 2017, 2336, (3), 1842-1854.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 左西替利嗪杂质51 as an Impurity". J. Nat. Prod., 2020, 614, 1306-1318.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Cetirizine Dihydrochloride EP Impurity E Using HRMS and NMR". Environ. Sci. Technol., 2010, 1329, (3), 8634-8664.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 左西替利嗪杂质51 Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2018, 1177, (9), 2903-2933.